http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3603745-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bcec623c18945c1b80a2f5273164f737
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-0626
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-0652
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-0624
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-062
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-0616
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-06
filingDate 2018-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59a0fb98450c8d300a144937a86f8494
publicationDate 2020-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-3603745-A1
titleOfInvention Therapy device for irradiating a surface of a tissue
abstract A therapy device for irradiating a surface (20) of a tissue, in particular skin tissue, is described which, in a multiple arrangement, has one or more first LEDs (22) with a first central wavelength and one or more second LEDs (26) with a second central wavelength The first central wavelength is suitable for carrying out a first type of phototherapy and the second central wavelength is suitable for simultaneously carrying out a second type of phototherapy on the tissue, the one or more first LEDs (22) and the one or more second LEDs (26) being separate are controllable as electrical operating variables with regard to their power and irradiation duration and each first LED (22) and every second LED (26) is each assigned an optical module (28) for the lateral limitation of the radiation in an exposure field (40, 50), so that the several first LEDs (22) first exposure fields (40) and several second LEDs (26) second exposure fields (50) are assigned, the first and second exposure fields (40, 50) being superimposed on the surface (20) of the tissue to form a common irradiation area (52), so that each first and second exposure field (40, 50) can be irradiated with a power and energy density above a therapy threshold for the first and second type of phototherapy with the most homogeneous power distributions possible.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114010955-A
priorityDate 2018-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004111132-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009088550-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004064923-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2940915-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2440287-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015112411-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408122
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID26124

Total number of triples: 24.